Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ)
CNY 8.13
(0.62%)
CNY 8.13
(0.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.49 Billion | 1.57 Billion | 1.35 Billion | 1.28 Billion | 1.15 Billion | 1.35 Billion |
| Cost of Revenue | 797.49 Million | 837.91 Million | 725.68 Million | 662.32 Million | 631.15 Million | 703.91 Million |
| Gross Profit | 692.95 Million | 735.14 Million | 632.18 Million | 619.03 Million | 526.23 Million | 650.79 Million |
| Operating Expenses | 405.25 Million | 499.68 Million | 440.55 Million | 367.09 Million | 391.22 Million | 332.09 Million |
| Selling, General and Administrative Expenses | 332.19 Million | 292.43 Million | 252.81 Million | 220.57 Million | 208.17 Million | 202.45 Million |
| Research and Development Expenses | 64.61 Million | 86.97 Million | 74.75 Million | 52.05 Million | 82.75 Million | 40.31 Million |
| Other Expenses | -14.39 Million | 120.26 Million | 112.98 Million | 94.46 Million | 100.3 Million | -5 Million |
| Cost and Expenses | 1.18 Billion | 1.33 Billion | 1.16 Billion | 1.02 Billion | 1.02 Billion | 1.03 Billion |
| Operating Income | 330.85 Million | 251.48 Million | 180.5 Million | 269.22 Million | 145.87 Million | 293.47 Million |
| Interest Expense | 2.83 Million | 6.79 Million | 12.94 Million | 19.65 Million | 25.51 Million | 9.87 Million |
| Income Tax Expense | 53.22 Million | 37.91 Million | 38.92 Million | 35.81 Million | 23.68 Million | 28.39 Million |
| Earnings before Tax | 329.69 Million | 250.21 Million | 178.88 Million | 63.74 Million | -500.66 Million | 288.46 Million |
| Net Income | 247.69 Million | 212.22 Million | 160.7 Million | 27.92 Million | -524.34 Million | 229.66 Million |
| Earnings Per Share Basic | 0.30 | 0.26 | 0.20 | 0.03 | -0.64 | 0.28 |
| Earnings Per Share Diluted | 0.30 | 0.26 | 0.20 | 0.03 | -0.64 | 0.28 |
| Weighted Average Shares Outstanding | 814.25 Million | 814.18 Million | 814.18 Million | 814.18 Million | 814.1 Million | 833.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 814.25 Million | 814.18 Million | 814.18 Million | 814.18 Million | 814.1 Million | 833.32 Million |
| Gross Margin | 0.46 | 0.47 | 0.47 | 0.48 | 0.45 | 0.48 |
| EBIT Margin | 0.28 | 0.25 | 0.22 | 0.28 | 0.20 | 0.30 |
| Profit Margin | 0.17 | 0.13 | 0.12 | 0.02 | -0.45 | 0.17 |
| EBITDA | 417.61 Million | 370.04 Million | 294.93 Million | 162.26 Million | -400.79 Million | 373.47 Million |
| Earnings Before Tax Margin | 0.22 | 0.16 | 0.13 | 0.21 | 0.13 | 0.22 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 324.86 Million | 348.05 Million | 361.83 Million | 1.49 Billion | 386.59 Million | 324.3 Million |
| Cost of Revenue | 169.92 Million | 178.37 Million | 180.78 Million | 797.49 Million | 206.19 Million | 169.63 Million |
| Gross Profit | 154.93 Million | 169.67 Million | 181.04 Million | 692.95 Million | 180.4 Million | 154.67 Million |
| Operating Expenses | 116.82 Million | 100.78 Million | 102.5 Million | 397.01 Million | 117.36 Million | 108.22 Million |
| Selling, General and Administrative Expenses | 193.57 Million | 84.93 Million | 85.69 Million | - | 94.22 Million | 128.01 Million |
| Research and Development Expenses | 14.64 Million | 14.3 Million | 17.1 Million | - | 18.59 Million | 15.76 Million |
| Other Expenses | -91.39 Million | -1.55 Million | 297.88 Thousand | -5.44 Million | -4.53 Million | -812.04 Thousand |
| Cost and Expenses | 286.74 Million | 279.16 Million | 283.29 Million | 1.19 Billion | 323.55 Million | 277.85 Million |
| Operating Income | 43.95 Million | 68.88 Million | 78.53 Million | 295.93 Million | 63.04 Million | 54.61 Million |
| Interest Expense | 610.26 Thousand | 732.4 Thousand | 725.9 Thousand | 2.57 Million | 644.09 Thousand | 624.7 Thousand |
| Income Tax Expense | 7.07 Million | 13.73 Million | 13.88 Million | 53.22 Million | 16.35 Million | 7.24 Million |
| Earnings before Tax | 42.67 Million | 86.78 Million | 95.77 Million | 330.95 Million | 73.33 Million | 53.8 Million |
| Net Income | 28.79 Million | 64.35 Million | 71.08 Million | 247.69 Million | 52.34 Million | 40.74 Million |
| Earnings Per Share Basic | 0.04 | 0.08 | 0.09 | - | 0.06 | 0.05 |
| Earnings Per Share Diluted | 0.04 | 0.08 | 0.09 | - | 0.06 | 0.05 |
| Weighted Average Shares Outstanding | 814.18 Million | 814.18 Million | 814.18 Million | 814.18 Million | 814.18 Million | 814.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 814.18 Million | 814.18 Million | 814.18 Million | 814.18 Million | 814.18 Million | 814.18 Million |
| Gross Margin | 0.48 | 0.49 | 0.50 | 0.46 | 0.47 | 0.48 |
| EBIT Margin | 0.13 | 0.25 | 0.26 | - | 0.21 | 0.16 |
| Profit Margin | 0.09 | 0.18 | 0.20 | 0.17 | 0.14 | 0.13 |
| EBITDA | 43.28 Million | 88.41 Million | 93.85 Million | - | 81.83 Million | 52.04 Million |
| Earnings Before Tax Margin | 0.14 | 0.20 | 0.22 | 0.20 | 0.16 | 0.17 |
ABNX
FHB
MLONL
CEFC
WSSTF
NCTKY